Proving once again that it only takes one press release to create a biotech buying flurry, Propanc Health Group Corporation (PPCH) rocked the OTC Tuesday on news of a possible cancer treatment breakthrough. Almost identical to how Rich Pharmaceuticals, Inc. (RCHA) burst through the “penny zone” in early February, shares of PPCH stock went wild, opening at 0.0053 and spiking to as high ...
Continue Reading →MAR